Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Salamon

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Biochemical and Biophysical Research Communications|March 7, 2018
Interferon γ is a strong, STAT1-dependent direct inducer of BCL6 expression in multiple myeloma cellsDorina Ujvari, Noemi Nagy, Harsha S Madapura, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
IL-21 imposes a type II EBV gene expression on type III and type I B cells by the repression of C- and activation of LMP-1-promoterLoránd L Kis, Daniel Salamon, Emma K Persson, et al.
Journal of Virology|February 21, 2012
Latency type-dependent modulation of Epstein-Barr virus-encoded latent membrane protein 1 expression by type I interferons in B cellsDaniel Salamon, Monika Adori, Dorina Ujvari, et al.
Plos One|August 28, 2014
The MEC1 and MEC2 lines represent two CLL subclones in different stages of progression towards prolymphocytic leukemiaEahsan Rasul, Daniel Salamon, Noemi Nagy, et al.
Genome Research|September 27, 2013
Large-scale hypomethylated blocks associated with Epstein-Barr virus-induced B-cell immortalizationKasper D Hansen, Sarven Sabunciyan, Ben Langmead, et al.
The Journal of General Virology|March 7, 2009
Binding of CCCTC-binding factor in vivo to the region located between Rep* and the C promoter of Epstein-Barr virus is unaffected by CpG methylation and does not correlate with Cp activityDaniel Salamon, Ferenc Banati, Anita Koroknai, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|January 29, 2003
The in vivo binding site for oncoprotein c-Myc in the promoter for Epstein-Barr virus (EBV) encoding RNA (EBER) 1 suggests a specific role for EBV in lymphomagenesisHans H Niller, Daniel Salamon, Karin Ilg, et al.
Journal of Virology|September 28, 2007
Acetylated histone H3 and H4 mark the upregulated LMP2A promoter of Epstein-Barr virus in lymphoid cellsBorbala Gerle, Anita Koroknai, György Fejer, et al.
Biochemical and Biophysical Research Communications|April 16, 2013
The role of DNA hypomethylation, histone acetylation and in vivo protein-DNA binding in Epstein-Barr virus-induced CD23 upregulationKalman Szenthe, Anita Koroknai, Ferenc Banati, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2012
Soluble factors produced by activated CD4+ T cells modulate EBV latencyNoémi Nagy, Mónika Adori, Abu Rasul, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Biochemical and Biophysical Research Communications|March 7, 2018
Interferon γ is a strong, STAT1-dependent direct inducer of BCL6 expression in multiple myeloma cellsDorina Ujvari, Noemi Nagy, Harsha S Madapura, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
IL-21 imposes a type II EBV gene expression on type III and type I B cells by the repression of C- and activation of LMP-1-promoterLoránd L Kis, Daniel Salamon, Emma K Persson, et al.
Journal of Virology|February 21, 2012
Latency type-dependent modulation of Epstein-Barr virus-encoded latent membrane protein 1 expression by type I interferons in B cellsDaniel Salamon, Monika Adori, Dorina Ujvari, et al.
Plos One|August 28, 2014
The MEC1 and MEC2 lines represent two CLL subclones in different stages of progression towards prolymphocytic leukemiaEahsan Rasul, Daniel Salamon, Noemi Nagy, et al.
Genome Research|September 27, 2013
Large-scale hypomethylated blocks associated with Epstein-Barr virus-induced B-cell immortalizationKasper D Hansen, Sarven Sabunciyan, Ben Langmead, et al.
The Journal of General Virology|March 7, 2009
Binding of CCCTC-binding factor in vivo to the region located between Rep* and the C promoter of Epstein-Barr virus is unaffected by CpG methylation and does not correlate with Cp activityDaniel Salamon, Ferenc Banati, Anita Koroknai, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|January 29, 2003
The in vivo binding site for oncoprotein c-Myc in the promoter for Epstein-Barr virus (EBV) encoding RNA (EBER) 1 suggests a specific role for EBV in lymphomagenesisHans H Niller, Daniel Salamon, Karin Ilg, et al.
Journal of Virology|September 28, 2007
Acetylated histone H3 and H4 mark the upregulated LMP2A promoter of Epstein-Barr virus in lymphoid cellsBorbala Gerle, Anita Koroknai, György Fejer, et al.
Biochemical and Biophysical Research Communications|April 16, 2013
The role of DNA hypomethylation, histone acetylation and in vivo protein-DNA binding in Epstein-Barr virus-induced CD23 upregulationKalman Szenthe, Anita Koroknai, Ferenc Banati, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2012
Soluble factors produced by activated CD4+ T cells modulate EBV latencyNoémi Nagy, Mónika Adori, Abu Rasul, et al.
Pageof 4